Roivios and Caresyntax Partner to Revolutionize Renal Care Through Data-Driven Insights | PR Newswire [Video]

, /PRNewswire/ — Roivios, a clinical-stage medical device company, and Caresyntax, a global leader in real-world evidence (RWE) and surgical intelligence, have joined forces to revolutionize renal care. This partnership aims to accelerate the integration of clinical and economic insights during product launch, driving the development of innovative medical technologies to improve patient outcomes and reduce healthcare costs.

Advancing Innovation in Kidney Health 

Central to this collaboration is the pivotal trial of Roivios’ JuxtaFlow® Renal Assist Device (RAD), an investigational technology specifically engineered to sustain or enhance kidney function for patients with renal impairment undergoing an on-pump cardiac surgery. This first-of-its-kind device has the potential to transform kidney care for high-risk patients.  

Caresyntax’s clinical data as a service (CDaaS) platform will capture RWE to complement the pivotal trial and help Roivios measure and optimize the value of the JuxtaFlow RAD. The partnership will establish a new model in renal disease management—one that prioritizes actionable clinical insights and financial efficacy …